FEVERALL SUPPOSITORIES OTC
Generic Name and Formulations:
Acetaminophen 80mg, 120mg, 325mg; rectal supps.
Indications for FEVERALL SUPPOSITORIES:
Minor pain. Fever.
Under 6 months: not recommended. 6–11 months: 80mg every 6hrs; max 4 doses/24hrs. 1–3yrs: 80mg every 4–6hrs; max 5 doses/24hrs. 3–6yrs: 120mg every 4–6hrs; max 5 doses/24hrs. 6–12yrs: 325mg every 4–6hrs; max 5 doses/24hrs. ≥12yrs: 650mg every 4–6hrs; max 6 doses/24hrs. All: as needed.
Hepatic dysfunction. Discontinue and reevaluate if fever or pain persists >72hrs or condition worsens. Pregnancy. Nursing mothers.
Hepatotoxicity risk increased by chronic, heavy alcohol use. Caution with concomitant warfarin. Avoid other acetaminophen-containing drugs.
Skin reactions (eg, reddening, blisters, rash; discontinue if occurs), hepatotoxicity (overdosage).
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- Clostridium Difficile Infection in Patients With Cancer — In the Clinic
- Targeted and Immunotherapies for Metastatic Renal Cell Carcinoma
- Atezolizumab, Carboplatin, Nab-Paclitaxel Combination Prolongs PFS in NSCLC
- Nicotinamide and Cancer
- FDA Approves Front-Line Brentuximab Vedotin Plus Chemotherapy for Hodgkin Lymphoma
- Opioid Prescription Protocol Decreases Opioid Use After Gynecologic Surgery
- Everolimus Plus Letrozole May Be Active in Recurrent Endometrial Carcinoma
- Affordable Care Act Increased Percentage of Insured Patients With Gynecologic Cancers
- Everolimus Plus Letrozole: An Effective First-Line Therapy for Advanced Breast Cancer
- FDA Approves Nilotinib for Pediatric Patients With CML